Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petra Tesarova

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|January 2, 2014
Breast cancer in the elderly-Should it be treated differently?Petra Tesarova
Biomed Research International|November 4, 2016
Specific Aspects of Breast Cancer Therapy of Elderly WomenPetra Tesarova
Journal of Personalized Medicine|December 31, 2020
Is It Possible to Personalize the Diagnosis and Treatment of Breast Cancer during Pregnancy?Petra Tesarova, David Pavlista, Antonin Parizek
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|February 6, 2016
HMGB1, S100 proteins and other RAGE ligands in cancer - markers, mediators and putative therapeutic targetsPetra Tesarova, Marta Kalousova, Tomas Zima, et al.
Lancet (London, England)|July 27, 2020
The link between kidney disease and cancer: complications and treatmentJolanta Malyszko, Petra Tesarova, Giovambattista Capasso, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 12, 2017
Polymorphisms of the receptor for advanced glycation end products and glyoxalase I and long-term outcome in patients with breast cancerPetra Tesarova, Tomas Zima, Ales A Kubena, et al.
Seminars in Thrombosis and Hemostasis|October 18, 2023
In Search of the Perfect Thrombosis and Bleeding-Associated Cancer ScaleMarek Z Wojtukiewicz, Petra Tesarova, Debora Karetová, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|May 23, 2017
Circulating tumor cells and serum levels of MMP-2, MMP-9 and VEGF as markers of the metastatic process in patients with high risk of metastatic progressionMarketa Skerenova, Veronika Mikulova, Otakar Capoun, et al.
Bratislavske Lekarske Listy|August 1, 2022
HER-3 molecular classification, expression of PD-L1 and clinical importance in breast cancerLibor Stanek, Robert Gurlich, Adam Whitley, et al.
Cancer Treatment Reviews|December 28, 2020
Drug dosing in cancer patients with decreased kidney function: A practical approachBen Sprangers, Geeta Sandhu, Mitchel H Rosner, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|January 2, 2014
Breast cancer in the elderly-Should it be treated differently?Petra Tesarova
Biomed Research International|November 4, 2016
Specific Aspects of Breast Cancer Therapy of Elderly WomenPetra Tesarova
Journal of Personalized Medicine|December 31, 2020
Is It Possible to Personalize the Diagnosis and Treatment of Breast Cancer during Pregnancy?Petra Tesarova, David Pavlista, Antonin Parizek
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|February 6, 2016
HMGB1, S100 proteins and other RAGE ligands in cancer - markers, mediators and putative therapeutic targetsPetra Tesarova, Marta Kalousova, Tomas Zima, et al.
Lancet (London, England)|July 27, 2020
The link between kidney disease and cancer: complications and treatmentJolanta Malyszko, Petra Tesarova, Giovambattista Capasso, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 12, 2017
Polymorphisms of the receptor for advanced glycation end products and glyoxalase I and long-term outcome in patients with breast cancerPetra Tesarova, Tomas Zima, Ales A Kubena, et al.
Seminars in Thrombosis and Hemostasis|October 18, 2023
In Search of the Perfect Thrombosis and Bleeding-Associated Cancer ScaleMarek Z Wojtukiewicz, Petra Tesarova, Debora Karetová, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|May 23, 2017
Circulating tumor cells and serum levels of MMP-2, MMP-9 and VEGF as markers of the metastatic process in patients with high risk of metastatic progressionMarketa Skerenova, Veronika Mikulova, Otakar Capoun, et al.
Bratislavske Lekarske Listy|August 1, 2022
HER-3 molecular classification, expression of PD-L1 and clinical importance in breast cancerLibor Stanek, Robert Gurlich, Adam Whitley, et al.
Cancer Treatment Reviews|December 28, 2020
Drug dosing in cancer patients with decreased kidney function: A practical approachBen Sprangers, Geeta Sandhu, Mitchel H Rosner, et al.
Pageof 3